"Max Smart Super Speciality Hospital, Saket (a unit of Gujarmal Modi Hospital & Research Centre for Medical Sciences) is a 250 bed facility with 12 high-end modular operation theatres, an emergency resuscitation and observation unit. The hospital is equipped with 72 critical care beds, a dedicated endoscopy unit and an advanced dialysis uniewst. It is a tertiary care hospital equipped with 256 Slice CT Angio, 3.0 Tesla digital broad band MRI, Cath Labs with electrophysiology navigation, and a flat panel C-Arm detector. It offers services in the medical disciplines of Orthopaedics, Obstetrics & Gynaecology, Paediatrics, Cardiac Sciences and Urology."

During the past decade, Max Smart Super Speciality Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Max Smart Super Speciality Hospital" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Cristcot HCA LLC" with 1 trials as a collaborator, "George Clinical Pty Ltd" with 1 trials as a collaborator and "Saint Luke's Hospital of Kansas City" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Max Smart Super Speciality Hospital" are "COVID-19" (1 trials) and "Ulcerative Proctitis" (1 trials). Many other conditions were trialed in "Max Smart Super Speciality Hospital" in a lesser frequency.

Most popular intervention types in "Max Smart Super Speciality Hospital" are "Combination Product" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dapagliflozin 10 milligram (mg)" (1 trials), "Once daily 90 mg hydrocortisone acetate or placebo suppository administered with Sephure applicator" (1 trials), "Placebo" (1 trials), "Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator" (1 trials) and "Twice daily placebo suppository administered with Sephure applicator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Max Smart Super Speciality Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Max Smart Super Speciality Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Max Smart Super Speciality Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Max Smart Super Speciality Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".